217 related articles for article (PubMed ID: 11228336)
1. Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty.
Wu CH; Chen YC; Hsiao G; Lin CH; Liu CM; Sheu JR
Thromb Res; 2001 Feb; 101(3):127-38. PubMed ID: 11228336
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms in the inhibition of neointimal hyperplasia with triflavin in a rat model of balloon angioplasty.
Sheu JR; Wu CH; Chen YC; Hsiao G; Lin CH
J Lab Clin Med; 2001 Apr; 137(4):270-8. PubMed ID: 11283521
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA.
Choi ET; Engel L; Callow AD; Sun S; Trachtenberg J; Santoro S; Ryan US
J Vasc Surg; 1994 Jan; 19(1):125-34. PubMed ID: 7508000
[TBL] [Abstract][Full Text] [Related]
4. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins.
Tam SH; Sassoli PM; Jordan RE; Nakada MT
Circulation; 1998 Sep; 98(11):1085-91. PubMed ID: 9736595
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis.
Baron JH; Moiseeva EP; de Bono DP; Abrams KR; Gershlick AH
Cardiovasc Res; 2000 Dec; 48(3):464-72. PubMed ID: 11090842
[TBL] [Abstract][Full Text] [Related]
6. [Expression of inducible nitric oxide synthase in the carotid of rats after endothelial skinning: the effects of platelets and treatment with abciximab].
González-Fernández F; Rodríguez-Feo JA; Farré J; Guerra J; Romero J; Gómez J; Rico L; Ayala R; Marcos P; Sánchez de Miguel L; Casado S; López-Farré A
Rev Esp Cardiol; 1999 Jun; 52(6):422-8. PubMed ID: 10373776
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates.
Deitch JS; Williams JK; Adams MR; Fly CA; Herrington DM; Jordan RE; Nakada MT; Jakubowski JA; Geary RL
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1730-7. PubMed ID: 9812911
[TBL] [Abstract][Full Text] [Related]
8. Potential non-glycoprotein IIb/IIIa effects of abciximab.
Coller BS
Am Heart J; 1999 Jul; 138(1 Pt 2):S1-5. PubMed ID: 10385784
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I: role of the macrophage and platelet-derived growth factor.
Rubin P; Williams JP; Riggs PN; Bartos S; Sarac T; Pomerantz R; Castano J; Schell M; Green RM
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):929-41. PubMed ID: 9531379
[TBL] [Abstract][Full Text] [Related]
10. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
[TBL] [Abstract][Full Text] [Related]
11. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Batchelor WB; Tolleson TR; Huang Y; Larsen RL; Mantell RM; Dillard P; Davidian M; Zhang D; Cantor WJ; Sketch MH; Ohman EM; Zidar JP; Gretler D; DiBattiste PM; Tcheng JE; Califf RM; Harrington RA
Circulation; 2002 Sep; 106(12):1470-6. PubMed ID: 12234950
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.
Chico TJ; Chamberlain J; Gunn J; Arnold N; Bullens SL; Gadek TR; Francis SE; Bunting S; Horton M; Shepherd L; Lipari MT; Quan C; Knolle J; Stilz HU; Peyman A; Crossman DC
Circulation; 2001 Feb; 103(8):1135-41. PubMed ID: 11222478
[TBL] [Abstract][Full Text] [Related]
13. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
Lele M; Sajid M; Wajih N; Stouffer GA
Circulation; 2001 Jul; 104(5):582-7. PubMed ID: 11479257
[TBL] [Abstract][Full Text] [Related]
14. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy.
Mascelli MA; Worley S; Veriabo NJ; Lance ET; Mack S; Schaible T; Weisman HF; Jordan RE
Circulation; 1997 Dec; 96(11):3860-6. PubMed ID: 9403608
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
Suzuki K; Sato K; Kamohara M; Kaku S; Kawasaki T; Yano S; Iizumi Y
Biol Pharm Bull; 2002 Aug; 25(8):1006-12. PubMed ID: 12186399
[TBL] [Abstract][Full Text] [Related]
16. IIb's are not IIb's.
Kereiakes DJ; Runyon JP; Broderick TM; Shimshak TM
Am J Cardiol; 2000 Apr; 85(8A):23C-31C. PubMed ID: 10793177
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty.
Wang X; Louden C; Ohlstein EH; Stadel JM; Gu JL; Yue TL
Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1365-72. PubMed ID: 8911275
[TBL] [Abstract][Full Text] [Related]
18. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice.
Choi ET; Khan MF; Leidenfrost JE; Collins ET; Boc KP; Villa BR; Novack DV; Parks WC; Abendschein DR
Circulation; 2004 Mar; 109(12):1564-9. PubMed ID: 15007005
[TBL] [Abstract][Full Text] [Related]
19. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting.
Kopp CW; Steiner S; Nasel C; Seidinger D; Mlekusch I; Lang W; Bartok A; Ahmadi R; Minar E
Stroke; 2003 Nov; 34(11):2560-7. PubMed ID: 14563968
[TBL] [Abstract][Full Text] [Related]
20. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
